Adar1 Capital Management, LLC Merrimack Pharmaceuticals Inc Transaction History

Adar1 Capital Management, LLC

  • $441 Billion
  • Q1 2024

A detailed history of Adar1 Capital Management, LLC transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 902,350 shares of MACK stock, worth $13.7 Million. This represents 3.02% of its overall portfolio holdings.

Number of Shares
902,350
Previous 549,418 64.24%
Holding current value
$13.7 Million
Previous $7.37 Billion 80.89%
% of portfolio
3.02%
Previous 2.63%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$13.06 - $15.0 $4.61 Million - $5.29 Million
352,932 Added 64.24%
902,350 $13.3 Billion
Q4 2023

Feb 14, 2024
BUY
$12.02 - $13.41 $6.6 Million - $7.37 Million
549,418 New
549,418 $7.37 Billion

Others Institutions Holding MACK

# of Institutions
65
Shares Held
9.18M
Call Options Held
64K
Put Options Held
3.2K
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email